We have detected that you are using an Ad Blocker.
PracticeUpdate is free to end users but we rely on advertising to fund our site. Please consider supporting PracticeUpdate by whitelisting us in your ad blocker.
We have sent a message to the email address you have provided, . If this email is not correct, please update your settings with your correct address.
The email address you provided during registration, , does not appear to be valid. Please update your settings with a valid address before to continue using PracticeUpdate.
Please provide your AHPRA Number to ensure that you are given the correct level of access to our site.
Published in Oncology

Journal Scan / Research · August 21, 2020

Effectiveness of Trastuzumab in Routine Practice for HER2+ Esophageal, Gastroesophageal, and Gastric Cancer

Clinical Oncology


Additional Info

Clinical Oncology
Effectiveness of Trastuzumab in Routine Clinical Practice: A Population-Based Study of Patients With HER-2-Positive Oesophageal, Gastroesophageal and Gastric Cancer
Clin Oncol (R Coll Radiol) 2020 Jul 31;[EPub Ahead of Print], SJ Merchant, W Kong, B Gyawali, T Hanna, W Chung, S Nanji, SV Patel, CM Booth

From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine.

Further Reading